title: New insights into the immunopathology and control of dengue virus infection.
abstract: Dengue virus poses a major threat to global public health: two-thirds of the world's population is now at risk from infection by this mosquito-borne virus. Dengue virus causes a range of diseases with a small proportion of infected patients developing severe plasma leakage that leads to dengue shock syndrome, organ impairment and bleeding. Infection with one of the four viral serotypes results in the development of homotypic immunity to that serotype. However, subsequent infection with a different serotype is associated with an increased risk of developing severe disease, which has led to the suggestion that severe disease is triggered by immunopathology. This Review outlines recent advances in the understanding of immunopathology, vaccine development and human monoclonal antibodies produced against dengue virus.
authors.affiliation: Division of Immunology and Inflammation, Department of Medicine, Hammersmith campus, Imperial College London, London W12 0NN, UK.
authors.forename: Gavin
authors.initials: G
authors.lastname: Screaton
authors.affiliation: Division of Immunology and Inflammation, Department of Medicine, Hammersmith campus, Imperial College London, London W12 0NN, UK.|Dengue Hemorrhagic Fever Research Unit, Office for Research and Development, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
authors.forename: Juthathip
authors.initials: J
authors.lastname: Mongkolsapaya
authors.affiliation: Division of Immunology and Inflammation, Department of Medicine, Hammersmith campus, Imperial College London, London W12 0NN, UK.|Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.
authors.forename: Sophie
authors.initials: S
authors.lastname: Yacoub
authors.affiliation: Division of Immunology and Inflammation, Department of Medicine, Hammersmith campus, Imperial College London, London W12 0NN, UK.
authors.forename: Catherine
authors.initials: C
authors.lastname: Roberts
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D003715:Dengue / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D053059:Dengue Vaccines / Q000276:immunology* / Q000627:therapeutic use; D003716:Dengue Virus / Q000254:growth & development / Q000276:immunology* / Q000502:physiology; D054884:Host-Pathogen Interactions / Q000187:drug effects / Q000276:immunology; D006801:Humans; D008018:Life Cycle Stages / Q000276:immunology; D018448:Models, Immunological; D013601:T-Lymphocytes / Q000276:immunology / Q000821:virology
chemical_list: D000911:Antibodies, Monoclonal; D053059:Dengue Vaccines